A2AR expression has been reported on a broad range of immune cells including conventional αβ T lymphocytes and NK cells but the expression of this receptor in the context of the tumor microenvironment has not been extensively investigated, and much less in a comparative analysis between subsets. Here, ADORA2A is linked to neoplasm.